In the EGFR-mutated NSCLC cells, HCC827 and HCC4006, erlotinib induces autophagy, and the autophagy inhibitor, chloroquine, enhances erlotinib sensitivity. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.